Synthesis and metabolic stability of a tritium-labelled substance P analogue.
D000818:Animals; D001681:Biological Assay; D003429:Cross Reactions; D004355:Drug Stability; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010446:Peptide Fragments; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D011863:Radioimmunoassay; D011865:Radioisotope Dilution Technique; D013373:Substance P / Q000031:analogs & derivatives* / Q000138:chemical synthesis; D014316:Tritium
D010446:Peptide Fragments; D014316:Tritium; D013373:Substance P; C032720:substance P (5-11), pGlu(5)-MePhe(8)-MeGly(9)-; D011761:Pyrrolidonecarboxylic Acid